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D 
riving  the  rapid  advance in  knowledge of peptide- 
binding to major histocompatibility complex (MHC) 
molecules is the prospect of predicting which peptides from 
foreign proteins are likely to be antigenic, and thus effective 
immunogens in vivo. Despite the numerous peptides  that 
theoretically could be generated from a foreign protein, in 
practice cytotoxic T lymphocytes  (CTL) focus upon just a 
few immunodomimnt peptide epitopes presented by self  MHC 
class I molecules (1). Underlying this selection of particular 
peptides, also called determinants, is the sequence polymor- 
phism that epitomizes  class I heavy chains (2). In general, 
differences between alleles map to the peptide-binding site 
of the class I molecule and serve to change the types of peptide 
bound. 
Molecular insight comes from two lines of evidence: three- 
dimensional structures of class I molecules bound to defined 
peptides, and amino acid sequences of endogenously bound 
peptides (3). Conserved residues in the peptide-binding site 
enmesh the peptide termini in hydrogen bond networks, 
interactions  that lay a foundation for high aftinity binding. 
Polymorphic pockets  of the class 1-binding site then add 
sequence specificity  to the interaction by selecting for particuhr 
amino acids at  two "anchor" positions  within a peptide 
sequence of eight to nine residues. The identity of the anchor 
residues and their position define minimum "allele-specific 
motifs" the relevance  of which is demonstrated by their ability 
to confer class I binding when incorporated into a polyala- 
nine peptide backbone (4, 5). This knowledge raised hope 
that scanning foreign protein sequences for the presence of 
particular  motifs would facilitate prediction of CTL epi- 
topes. Indeed in notable instances this has been achieved. The 
H-2K  d peptide-binding motif was used to identify a pro- 
tective CTL epitope from Listeria monocytogenes (6, 7), and 
Hill et al. (8) found a CTL epitope from Plasmodiumfaki~rum 
that may protect individuals who express HLA-B*5301 from 
severe malaria. 
Although most functionally defined CTL epitopes possess 
appropriate class I-binding motifs (9), a minority of motif- 
containing peptides from a given foreign protein are actually 
immunogenic. For example, although ovalbumin (a favorite 
model antigen)  contains  six  potential  epitopes  with  the 
H-2Kb-binding motif (shown in Table 1)  (10), the CTL 
response  is  dominated by just  one,  OVA2s7-264 (12, 13). 
Immunodominance  is dictated by more than just the presence 
of an appropriate class I-binding motif, which seems hardly 
surprising because antigen presentation  involves many steps 
before the binding of class I and peptide:  antigenic protein 
undergoes proteolysis, transport to the endoplasmic reticulum, 
and competes there with other peptides for binding to class 
I molecules. Seeking an explanation for the immunodominance 
of OVAz57_~, Jameson and Bevan (10) showed that synthetic 
peptides corresponding to the six ovalbumin sequences vary 
widely in their ability to bind H-2K  b, as measured by ability 
to promote stable class I assembly. Interestingly,  OVA2sT-~ 
was the most efficient, suggesting epitope selection reflects 
superior binding affinity. 
Recent investigations evaluate the contribution of peptide 
affinity for class I molecules to epitope selection, with the 
goal of improving identification of potential CTL epitopes. 
One such study is reported in this issue by Chen et al. (14) 
who find that immunization of mice with high concentra- 
tions of ovalbumin leads to CTL against a second epitope, 
OVAss-62. In  pursuit  of the  basis for  dominance of the 
OVA2sr  CTL  response  over  that  to  OVAss-62 
under less extreme conditions of immunization, they showed 
the relatively poor response to OVAss-62 could not be attrib- 
uted to bias in the T cell repertoire  as equivalent numbers 
of CTL respond to both epitopes. Thus, the onus was placed 
on differences  in peptide generation and/or presentation. This 
suspicion was confirmed by comparison ofT cell hybridomas 
specific for  OVA2sT-~ and  OVAs~2,  which  showed  the 
dominant epitope was processed  and presented some 20-50-fold 
more efficiently than the sub-dominant epitope. Furthermore, 
a synthetic version of the dominant epitope  strongly out 
competed T cell hybridoma recognition of the sub-dominant 
epitope and not vice versa. On this basis, the source of domi- 
nance was attributed  to differences in binding to H-2K  b. 
Quantitative affinity measurements were therefore undertaken 
using  biosensor-based  technology  that  employes  surface 
plasmon resonance (SPR) to monitor binding of immobilized 
peptide analogues to a soluble form of H-2K  b (Fig. 1) (15). 
Although several methods have been developed for studying 
peptide-MHC binding, they are based on measurement of 
affinity constants  at equilibrium. SPR offers the advantage 
of direct and continuous monitoring of changes in concen- 
tration of soluble class I molecules at the biosensor surface, 
enabling association and dissociation kinetics to be measured 
as they occur (in real time).  The association  rate  for  the 
OVA2sT-264 analogue was found to be approximately  10-fold 
faster than that of OVAss-62, and a two to three-fold differ- 
ence in the dissociation rates of the two peptides was also 
observed. Thus, Chen et al. (14) conclude that functional 
dominance of OVA2s~-~64 in vivo can be explained  almost 
completely by its high affinity binding to H-2K  b. 
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Volume  180  October 1994  1191-1194 Table  1.  Sequences  of Peptides from Ovalbumin which Contain 
the H-2K~-binding Motif 
Motif-containing 
peptides  Peptide sequences 
OVA12-19  CFDVFKEL 
OVA2s-32  EN I FYCP I 
OVAs~2  KVVRFDKL 
OVA10";,-it4  AEERYP I L 
OVAI?6-1s3  NAI VFKGL 
0VA257-264  S I I NFEKL 
Subscript numbers refer to location of the peptide in the ovalbumin se- 
quence. Peptide sequences are given in the single-letter code. The H-2K  b- 
binding motif proposed by Falk et al. (11) comprises phenylalanine or 
tyrosine at position 5 and leucine or isoleucine at the COOH-terminal 
position  of an octamer peptide. 
Other  investigators  also conclude that  superior  class I 
binding is an influential factor in the selection of CTL epi- 
topes from peptides  sharing minimum motifs.  Ruppert et 
al. (16) employed an assay in which the ability of test pep- 
tides to compete with a radiolabeled  standard  peptide for 
binding to detergent solubilized class I is used to quantita- 
tively assess affinities. Large variations  in affinity were de- 
tected when an assortment of tumor and viral antigens con- 
taining  the  minimum HLA-A*O2Ol-binding  motif were 
LIO~T  DE'I'F.Eq'IO~  OF  C~NOES 
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Figure  1.  Schematic representation of the biosensor used to quantify 
the binding kinetics of ovalbumin peptide analogues to H-2Kb molecules. 
Biosensors perform real time kinetic measurement of molecular interac- 
tions. Ovalbumin  peptide analogues substituted with cysteine at position 
6 were used to facilitate covalent coupling to the dextran-coated gold sur- 
face of the biosensor flow cell. Binding of soluble H-2K  b molecules (emp- 
tied of endogenous peptides by prior exposure to pH 12.5 to increase pep- 
tide binding capacity) to immobilized peptide generates changes in the 
refractive index of the medium adjacent to the biosensor surface. This in 
turn induces shifts in the resonance angle of reflected light from the oppo- 
site face of the biosensor. Shifts in SPK therefore correlate directly with 
binding of H-2K  b to immobilized peptide. 
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assayed, but most known CTL epitopes were among the high 
affinity binders. Similarly Parker et al. (17) using yet another 
assay, in which the strength of peptide binding is inversely 
correlated  with  the dissociation  rate of ~2-microglobulin 
from HLA-A*0201 molecules reconstituted with the peptide 
under test,  showed  that  dominant antigenic  epitopes  are 
amongst those that bind most tightly. 
Apparent from these studies is that minimum motifs are 
not the final say in defining a tightly binding peptide.  To 
search for additional dues, Kuppert et al. (16) aligned HLA- 
A'0201-binding peptides and correlated their sequences with 
strength of binding. This ex~dse revealed  common "secondary 
anchors" which when added to the dominant anchors pro- 
duce an expanded HLA-A~  motif that better predicts 
high affinity binding. Similarly, minimum motifs for HLA- 
A*0201,  HLA-A*0101, HLA-A*0301,  HLA-A*1101,  and 
HLA-A*2401 were refined by assessing relative acceptance 
of different amino acid substitutions  at the dominant anchor 
positions and including those tolerated into an expanded motif 
(18). Minimum motifs for these alleles predict only 27% of 
the high affinity binders from 240 possible nonamer peptides 
of the human papillomavirus  type 16 E6 and E7 proteins, 
but expanded motifs were present in 73% of the high affinity 
binders (19). Validation that expanded motifs improve epi- 
tope identification  awaits determination of whether these 
predicted peptides are dominant epitopes in CTL responses 
to papillomavirus. 
Use of ever-expanding motifs to predict peptide-binding 
strength presumes each amino add in the sequence contributes 
independently to affinity. Howev~, this assumption may some- 
times come unstuck. Indeed, in comparing their high and 
low affinity OVA peptides, Chen et al. (14) could not discern 
the structural basis for high aEinity binding by OVAzs?-264. 
ILeciprocal substitutions  between OVAzs7-~4 and OVAss-62 
failed to identify single positions that could explain the affinity 
differences; rather the effect was attributed to the collective 
sequence. While the essence of an epitope that gives enhanced 
affinity for class I resists rationalization,  identification of the 
most immunogenic peptides may still require direct assess- 
ment of relative affinity for the presenting class I molecule. 
Although peptide affinity for class I molecules clearly has 
a role in selecting determinants recognized by CTL, consider- 
ation of factors besides the chemistry of peptide binding may 
also be necessary if epitope prediction is to be successful  (Table 
2). Illustrating this point is a naturally processed decamer 
peptide from calreticulin bound by HLA-A*0201 which has 
considerably  less affinity  than  the  related  but  unnatural 
nonamer peptide lacking the COOH terminal amino acid 
(20). The failure of HLA-A'0201 to present  the nonamer 
peptide in vivo points to the importance of processes involved 
in peptide supply. 
The influences of proteolytic mechanisms, peptide stability, 
peptide transport,  and the T cell repertoire on CTL responses 
have been relatively ignored. The ability of 20S proteasomes 
to process ovalbumin has been =r  using an in vitro 
assay system, and generation of the dominant CTL epitope 
OVA2s~-~ was observed but the OVAss-62 peptide could not 
be detected (21). Thus although Chen et al. (14) show pep- Table  2.  Factors  during Antigen Processing and Presentation In  Vivo which May Influence the Ability of a Peptide to Form 
a CTL Epitope 
Concentration  of antigenic  protein  at  the site of intracellular  processing 
Ubiquitination  of antigenic  protein  to target  it for processing 
Specificity of the proteolytic enzymes  involved in antigen  processing 
Rate of peptide  generation  (influenced by protein  unfolding;  sequences flanking  the peptide) 
Stability of peptide  (rate of peptide degradation) 
Selective transport  of peptides into the endoplasmic reticulum 
Selective peptide  binding  by class I molecules 
Kinetics of peptide binding  and consequent  influence on competiton with other class I-binding peptides 
Efficiency of peptide presentation  to CTL (influenced by the number of class I-peptide complexes and presence of co-stimulatory 
molecules at antigen-presenting  cell surface) 
Presence of CTL with appropriate  peptide  specificity 
CTL with appropriate  peptide  specificity may be rendered  anergic due to cross-reactivity with self peptides 
tide affinity for class I can offer a complete explanation for 
the  immunodominance  of OVA2sT-2~4, inefficient  epitope 
generation may also contribute to failure of OVAss-62 to in- 
duce a  strong  CTL  response.  To  fully evaluate  the  latter 
possibility, further experiments may need to assess peptide 
generation by 26S proteolytic complexes since processing of 
OVA is dependent upon ubiquitination of the protein (22). 
Confirmation that predicted CTL epitopes can be generated 
in vivo will be crucial if synthetic versions are to be useful 
as vaccines against intraceUular  pathogens. There is obviously 
no point in promoting a CTL response to a predicted an- 
tigen if it is never presented during  infection in vivo. 
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